These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

910 related items for PubMed ID: 16685192

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Measuring and targeting aldosterone and renin in atherosclerosis-a review of clinical data.
    Hillaert MA, Lentjes EG, Beygui F, Kemperman H, Asselbergs FW, Nathoe HM, Agostoni P, Voskuil M, Ivanes F, Jude B, Bertrand ME, Pasterkamp G, van der Graaf Y, Doevendans PA, Montalescot G, Van Belle E.
    Am Heart J; 2011 Oct; 162(4):585-96. PubMed ID: 21982648
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Arterial stiffness and the renin-angiotensin-aldosterone system.
    Mahmud A, Feely J.
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):102-8. PubMed ID: 15526244
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Renin-angiotensin-aldosterone system (RAAS) and its pharmacologic modulation].
    Giestas A, Palma I, Ramos MH.
    Acta Med Port; 2010 Sep; 23(4):677-88. PubMed ID: 20687997
    [Abstract] [Full Text] [Related]

  • 12. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z, Armaly Z, Nakhoul F, Hoffman A.
    Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hypertension: renin-angiotensin-aldosterone system alterations.
    Te Riet L, van Esch JH, Roks AJ, van den Meiracker AH, Danser AH.
    Circ Res; 2015 Mar 13; 116(6):960-75. PubMed ID: 25767283
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Role of the renin-angiotensin-aldosterone system and inflammatory processes in the development and progression of diastolic dysfunction.
    Sciarretta S, Paneni F, Palano F, Chin D, Tocci G, Rubattu S, Volpe M.
    Clin Sci (Lond); 2009 Mar 13; 116(6):467-77. PubMed ID: 19200056
    [Abstract] [Full Text] [Related]

  • 19. A clinical approach in regression of glomerulosclerosis.
    Stoian M, Radulian G, Chiţac D, Simion E, Stoica V.
    Rom J Intern Med; 2007 Mar 13; 45(2):215-8. PubMed ID: 18333378
    [Abstract] [Full Text] [Related]

  • 20. Role of the renin-angiotensin system in vascular inflammation.
    Marchesi C, Paradis P, Schiffrin EL.
    Trends Pharmacol Sci; 2008 Jul 13; 29(7):367-74. PubMed ID: 18579222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.